Back to search results

Acupuncture for Hot Flashes in Men with Prostate Cancer

This study is for men with prostate cancer who are experiencing moderate to severe hot flashes due to hormone therapy (androgen deprivation therapy, or ADT). Many men on ADT experience hot flashes, poor sleep, and fatigue, and there isn't a standard treatment for these side effects. This study aims to see if acupuncture, a treatment where thin needles are inserted into the body, can help reduce hot flashes and related symptoms in men, similar to how it has helped women with breast cancer. You would be at least 18 years old and have prostate cancer confirmed by a doctor. The study will enroll 24 participants to see if this approach is practical and if people will engage with the acupuncture treatment over 12 to 18 months.

Study design
This is a pilot study with 24 participants, randomly assigned to receive either immediate acupuncture or delayed acupuncture. It's designed to see if the study itself is feasible.
What's involved
If you receive immediate acupuncture, you will have weekly 30-minute acupuncture sessions for 10 weeks, plus lifestyle education. If you receive delayed acupuncture, you will have lifestyle education for 10 weeks, then begin weekly 30-minute acupuncture sessions.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for a total of 22 weeks after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07335224

Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture

Recruiting
NAAges 18+InterventionalSupportive care
Inova Health Care Services
~24 participants
Updated 2026-02-04 on ClinicalTrials.gov
What's tested:AcupunctureLifestyle Management

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Study feasibility - patient enrollment
Measured over 12 months
+1 more outcome measured

Conditions

Hot Flashes
Acupuncture Therapy
Vasomotor Symptoms
Androgen Deprivation Therapy
Prostatic Neoplasms

Explore related trials

Prostate Carcinoma

Where it's being run

1 sites across 1 states
Virginia1

Study leadership

  • Jeanny Aragon-Ching, MD · PRINCIPAL_INVESTIGATOR · Inova Schar Cancer

Who to contact

Melissa F Miller, phD, MPH
[email protected]
(571) 232-8306
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male
At least 18 years of age
Histologically or cytologically confirmed adenocarcinoma of prostate of any stage I-IV
Undergoing androgen deprivation therapy (ADT) and/or androgen receptor pathway inhibitors
Experiencing moderate to severe daily interference from hot flashes, as indicated by the Hot Flash Related Daily Interference Scale (score≥4)
Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
Able to read, understand, and provide written informed consent

Exclusion

Severe or uncontrolled concurrent disease, infection or co-morbidity that, in the opinion of the Investigator, would make the patient inappropriate for enrollment
Known hypersensitivity to the acupuncture needles
Any condition that in the opinion of the Investigator would impair the patients' ability to comply with the study procedures
Unable to comply with study requirements
Use of acupuncture for hot flashes within 6 months prior to enrollment

What this trial measures

  • Study feasibility - patient enrollment12 months

    Study feasibility will be measured by patient enrollment rates, defined as the proportion of eligible patients approached about the study who consent to participate.

  • Study feasibility - Patient intervention engagement18 months

    Study feasibility will be measured by patient intervention engagement, defined as the proportion of enrolled patient subjects who attend at least 6 of 10 scheduled acupuncture visits.